ArticleEpidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?Author:Amy Forrestel, MDPublish date: December 30, 2022Symmetrical drug-related intertriginous and flexural exanthema is an uncommon but increasingly recognized cutaneous adverse event of epidermal grow...Read More
